2,4,5-Trichloropyrimidine → HCID 68782816, compound
Reaction equation
[CH3:1][N:2]1[CH:6]=[C:5]([NH2:7])[CH:4]=[N:3]1.[NH2:8][C@@H:9]1[C@@H:14]2[CH2:15][C@@H:11]([CH:12]=[CH:13]2)[C@@H:10]1[C:16]([NH2:18])=[O:17].Cl[C:20]1[N:25]=[C:24](Cl)[C:23]([Cl:27])=[CH:22][N:21]=1.ClC1N=[C:33](Cl)[C:32](F)=[CH:31]N=1>>[Cl:27][C:23]1[C:22]([NH:8][C@@H:9]2[C@@H:14]3[CH2:15][C@@H:11]([CH:12]=[CH:13]3)[C@@H:10]2[C:16]([NH2:18])=[O:17])=[N:21][C:20]([NH:7][C:5]2[CH:4]=[N:3][N:2]([CH2:1][CH2:33][C:32]3[CH:31]=[CH:11][CH:10]=[CH:9][CH:14]=3)[CH:6]=2)=[N:25][CH:24]=1Participants
5
Procedure
The title compound was prepared as described in Example 1, substituting 1-(2-phenylethyl)-1H-pyrazol-4-amine for 1-methyl-1H-pyrazol-4-amine in Example 1B along with substitution of (+)-(1S,2S,3R,4R)-3-aminobicyclo[2.2.1]hept-5-ene-2-carboxamide for (+/−)-(1S,2S,3R,4R)-3-aminobicyclo[2.2.1]hept-5-ene-2-carboxamide and 2,4,5-trichloropyrimidine for 2,4-dichloro-5-fluoropyrimidine in Example 1A. 1H NMR (300 MHz, DMSO-d6) ppm 1.40 (d, J=8.72 Hz, 1H) 2.09 (d, J=8.72 Hz, 1H) 2.74 (s, 1H) 2.88 (s, 1H) 3.06 (t, J=7.34 Hz, 2H) 4.00-4.11 (m, 1H) 4.26 (t, J=7.34 Hz, 2H) 6.25 (d, J=5.55 Hz, 1H) 6.36 (d, J=5.55 Hz, 1H) 7.06-7.33 (m, 6H) 7.52 (s, 1H) 7.65 (s, 1H) 7.80 (s, 1H) 7.88 (s, 1H) 9.09 (s, 1H); MS (ESI(+)) m/e 450 (M+H)+.
Sources & evidence
- ORD record
- ord-64aef5cc519749fa89f87c5eea864cfc
- Source dataset
- uspto-grants-2013_04
- Patent number
- US08426408B2
Reaction notes
Loading…